Terms: = Pancreatic cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
44 results:
1. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
[TBL] [Abstract] [Full Text] [Related]
2. ndrg1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
[TBL] [Abstract] [Full Text] [Related]
3. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
[TBL] [Abstract] [Full Text] [Related]
4. cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor.
Zhao Y; Lu T; Song Y; Wen Y; Deng Z; Fan J; Zhao M; Zhao R; Luo Y; Xie J; Hu B; Sun H; Wang Y; He S; Gong Y; Cheng J; Liu X; Yu L; Li J; Li C; Shi Y; Huang Q
Adv Sci (Weinh); 2023 Mar; 10(8):e2204177. PubMed ID: 36658726
[TBL] [Abstract] [Full Text] [Related]
5. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
Brogyányi T; Kaplánek R; Kejík Z; Hosnedlová B; Antonyová V; Abramenko N; Veselá K; Martásek P; Vokurka M; Richardson DR; Jakubek M
Biomed Pharmacother; 2022 Nov; 155():113736. PubMed ID: 36156366
[TBL] [Abstract] [Full Text] [Related]
6. Protein expression profiling identifies a prognostic model for ovarian cancer.
Xiong L; Tan J; Feng Y; Wang D; Liu X; Feng Y; Li S
BMC Womens Health; 2022 Jul; 22(1):292. PubMed ID: 35840928
[TBL] [Abstract] [Full Text] [Related]
7. Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia.
Richardson DR; Azad MG; Afroz R; Richardson V; Dharmasivam M
Future Med Chem; 2022 Jul; 14(13):1005-1017. PubMed ID: 35670251
[TBL] [Abstract] [Full Text] [Related]
8. The Oncogenic Signaling Disruptor, ndrg1: Molecular and Cellular Mechanisms of Activity.
Chekmarev J; Azad MG; Richardson DR
Cells; 2021 Sep; 10(9):. PubMed ID: 34572031
[TBL] [Abstract] [Full Text] [Related]
9. The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection.
Yanagaki M; Haruki K; Yasuda J; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Gocho T; Taniai T; Hamura R; Ikegami T
Ann Surg Oncol; 2021 Dec; 28(13):8130-8139. PubMed ID: 34490525
[TBL] [Abstract] [Full Text] [Related]
10. Robotic Total Pancreatectomy: A Narrative Review.
Takagi K; Koerkamp BG
In Vivo; 2021; 35(4):1907-1911. PubMed ID: 34182462
[TBL] [Abstract] [Full Text] [Related]
11. Robotic versus open total pancreatectomy: a retrospective cohort study.
Wang W; Liu Q; Zhao Z; Tan X; Zhao G; Liu R
Langenbecks Arch Surg; 2021 Nov; 406(7):2325-2332. PubMed ID: 34057600
[TBL] [Abstract] [Full Text] [Related]
12. Robotic Total Pancreatectomy: A Novel pancreatic Head-First Approach (with Video).
Takagi K; Koerkamp BG
J Gastrointest Surg; 2021 Jun; 25(6):1649-1650. PubMed ID: 33570722
[TBL] [Abstract] [Full Text] [Related]
13. Breaking the cycle: Targeting of ndrg1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma.
Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z
FASEB J; 2021 Feb; 35(2):e21347. PubMed ID: 33484481
[TBL] [Abstract] [Full Text] [Related]
14. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Viúdez A; Crespo G; Gómez Dorronsoro ML; Arozarena I; Marín-Méndez JJ; Custodio A; Benavent M; Goñi S; García-Paredes B; Hernando J; Durantez M; Alonso V; Riesco MDC; López C; Jiménez-Fonseca P; San Vicente BL; González-Borja I; Sevilla I; Hernández-Garcia I; Carmona-Bayonas A; Capdevila J; Pérez-Sanz J; García-Carbonero R; Pérez-Ricarte L; Llanos M; Vera R; De Jesús Acosta A
Pancreatology; 2021 Jan; 21(1):215-223. PubMed ID: 33358592
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the ndrg1/NF-κB/E-cadherin axis.
Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
[TBL] [Abstract] [Full Text] [Related]
16. ndrg1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
Sahni S; Gillson J; Park KC; Chiang S; Leck LYW; Jansson PJ; Richardson DR
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129625. PubMed ID: 32335136
[TBL] [Abstract] [Full Text] [Related]
17. The metastasis suppressor, ndrg1, differentially modulates the endoplasmic reticulum stress response.
Merlot AM; Porter GM; Sahni S; Lim EG; Peres P; Richardson DR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2094-2110. PubMed ID: 30981813
[TBL] [Abstract] [Full Text] [Related]
18. Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1.
Sahni S; Park KC; Kovacevic Z; Richardson DR
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1361-1378. PubMed ID: 30763642
[TBL] [Abstract] [Full Text] [Related]
19. The metastasis suppressor, ndrg1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells.
Menezes SV; Fouani L; Huang MLH; Geleta B; Maleki S; Richardson A; Richardson DR; Kovacevic Z
Carcinogenesis; 2019 Jul; 40(6):805-818. PubMed ID: 30561520
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic value of decreased ndrg1 expression in patients with digestive system cancers: A meta-analysis.
Chen K; Liu XH; Wang FR; Liu HP; Huang ZP; Chen X
Medicine (Baltimore); 2018 Oct; 97(41):e12455. PubMed ID: 30313035
[TBL] [Abstract] [Full Text] [Related]
[Next]
